ScholarIQanswers from OpenAlex

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2

PaperCitations, authors & open-access status

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 have?

ScholarIQcitation count

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 has 44 citations in the OpenAlex counts ScholarIQ stores.

When was SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 published?

ScholarIQyear

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 has 2018 year in the ScholarIQ index.

What is the open-access status of SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2?

ScholarIQoa status

SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 has hybrid oa status in the ScholarIQ index.

What is the DOI of SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2?

ScholarIQdoi

The DOI for SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 is on the source record.

What is the PMID of SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2?

ScholarIQpmid

The PMID for SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 is on the source record.

What is the OpenAlex record for SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2?

ScholarIQopenalex

The OpenAlex for SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial